1. Home
  2. FIVN vs VIR Comparison

FIVN vs VIR Comparison

Compare FIVN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five9 Inc.

FIVN

Five9 Inc.

HOLD

Current Price

$17.93

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.82

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVN
VIR
Founded
2001
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
FIVN
VIR
Price
$17.93
$9.82
Analyst Decision
Buy
Strong Buy
Analyst Count
19
8
Target Price
$26.32
$19.63
AVG Volume (30 Days)
2.9M
4.2M
Earning Date
05-21-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
364.71
17.49
EPS
0.45
N/A
Revenue
$1,149,088,000.00
$68,556,000.00
Revenue This Year
$11.39
N/A
Revenue Next Year
$10.00
$925.73
P/E Ratio
$40.24
N/A
Revenue Growth
10.28
N/A
52 Week Low
$15.70
$4.16
52 Week High
$31.75
$10.91

Technical Indicators

Market Signals
Indicator
FIVN
VIR
Relative Strength Index (RSI) 51.39 63.90
Support Level $18.03 $4.95
Resistance Level $18.96 $10.91
Average True Range (ATR) 1.15 0.69
MACD 0.13 0.07
Stochastic Oscillator 44.63 69.49

Price Performance

Historical Comparison
FIVN
VIR

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: